IPHA
Innate Pharma
IPHA
IPHA
18 hedge funds and large institutions have $5.82M invested in Innate Pharma in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+13
Holders Change %
+260%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
2
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Millennium Management
New York
|
$167K |
2 |
Morgan Stanley
New York
|
$109K |
3 |
SPIA
Steward Partners Investment Advisory
New York
|
$3K |